Paloma Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Paloma Partners’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-250,000	Closed	-$43.2M	–	2085
2015 Q1	$43.2M	Buy	+250,000	New	+$36.7M	1.22%	7
2014 Q4	–	Sell	-13,273	Closed	-$1.61M	–	1550
2014 Q3	$2.07M	Buy	+13,273	New	+$1.92M	0.1%	212

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Paloma Partners's SLXP Position: Q2 2015 in Review

Paloma Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 250,000 shares — an estimated $43.2M sold.

Paloma Partners first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $43.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Paloma Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Paloma Partners sold 250,000 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $43.2M.
Paloma Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
Paloma Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $43.2M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Paloma Partners's 13F filing for Q2 2015, filed 14 Aug 2015.